Peer-reviewed veterinary case report
How levobupivacaine spreads in dogs after dental nerve blocks
By Pavlica, Matic et al.·Published in Frontiers in veterinary science·2022·Small Animal Clinic·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: The pharmacokinetics of levobupivacaine 0.5% after infraorbital or inferior alveolar block in anesthetized dogs.
- Species:
- dog
Plain-English summary
Ten dogs undergoing dental surgery received a local anesthetic called levobupivacaine to numb their mouths. Blood samples were taken to see how the drug was absorbed and how long it stayed in their system. The results showed that the drug levels were much lower than what would cause toxicity, and none of the dogs showed any serious side effects like heart issues or nervous system problems. This suggests that levobupivacaine is safe for use in dogs during dental procedures.
People also search for: dog dental surgery anesthesia · levobupivacaine safety for dogs · local anesthetic for dog teeth cleaning
Abstract
INTRODUCTION: Data are lacking on the pharmacokinetic profile and safety of levobupivacaine (LB) used for regional anesthesia of the maxilla and mandibles in dogs. METHODS: Infraorbital block (= 10), inferior alveolar block (= 10) or both infraorbital and inferior alveolar blocks (= 10) were administered to dogs undergoing dental surgery under isoflurane anesthesia. The dose of LB was calculated as 0.11 ml/kgfor the infraorbital block and 0.18 ml/kgfor the inferior alveolar block. Blood samples were collected before and immediately after administration of the oral blocks, and 3, 4, 7, 12, 17, 32, 47, 62, 92, and 122 min thereafter. Quantification of LB in plasma was performed by LC-MS/MS. RESULTS AND DISCUSSION: The results are presented as median and interquartile range. In dogs in which all four quadrants of the oral cavity were desensitized with LB, thewas 1,335 (1,030-1,929) ng/ml, thewas 7 (4-9.5) min, and the AUCwas 57,976 (44,954-96,224) ng min/ml. Plasma concentrations of LB were several times lower than the reported toxic concentrations, and no signs of cardiovascular depression or neurotoxicity were observed in any of the dogs, suggesting that the occurrence of severe adverse effects after administration of LB at the doses used in this study is unlikely.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/36590797/